Immunisation at the crossroads: 9th National Immunisation/1st Asia-Pacific Vaccine Preventable Diseases Conference

Medical Journal of Australia

Volumn 182, Issue 1, 2005, Pages 15-16

  McIntyre, Peter B ^a   Kelly, Heath A ^b   Mulholland, E Kim ^c  

^a National Centre for Immunisation Research   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; ROTAVIRUS VACCINE; VACCINE; VIRUS VACCINE;

ASIA; BACTERIAL PNEUMONIA; CHILD HEALTH CARE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EPIDEMIC; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE FINANCING; HEALTH PROGRAM; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFLUENZA; INTUSSUSCEPTION; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PACIFIC ISLANDS; STREPTOCOCCUS INFECTION; VACCINATION; VIRUS INFECTION; WART VIRUS;

EID: 11844262098     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06547.x     Document Type: Conference Paper

References (8)

1. McIntyre F, Gidding H, Gilmour R, et al. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Canberra: Australian Government, Australian Institute of Health and Welfare, 2002.
2. Lester R, Pitcher H, Pellisier S, Robinson P. Vaccination against serogroup C meningococcal disease. Vic Infect Dis Bull 2002; 5: 26-28.
3. Trotter CL, Andrews NJ, Kaczmarski EB, et al. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004; 364: 365-367.
4. Madhi SA, Klugman KP; The Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004; 10: 811-813.
5. Andrews R, Counihan M, Hogg G, McIntyre P. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia. Vaccine 2004; 23: 132-138.
6. Flannery B, Schrag S, Bennett NM, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 2004; 291: 2197-2203.
7. Mulholland K, Hilton S, Adegbola R, et al. Randomised trial of Haemophilus influenzae type b-tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997; 349: 1191-1197.
8. Ramsay ME, McVernon J, Andrews NJ, et al. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis 2003; 188: 481-485.